4399免费视频

山東(dong)泰(tai)邦生(sheng)(sheng)物(wu)(wu)(wu)制(zhi)(zhi)(zhi)品(pin)(pin)有(you)(you)限(xian)公(gong)(gong)司(si)(si)簡介山東(dong)泰(tai)邦生(sheng)(sheng)物(wu)(wu)(wu)制(zhi)(zhi)(zhi)品(pin)(pin)有(you)(you)限(xian)公(gong)(gong)司(si)(si)是在山東(dong)省(sheng)生(sheng)(sheng)物(wu)(wu)(wu)制(zhi)(zhi)(zhi)品(pin)(pin)研究所(suo)與外商(shang)于(yu)(yu)二(er)00二(er)年(nian)十一月(yue)成立的(de)(de)(de)(de)(de)合(he)資(zi)(zi)企(qi)業。是以血(xue)液(ye)制(zhi)(zhi)(zhi)品(pin)(pin)、基因工程產(chan)(chan)(chan)品(pin)(pin)和(he)生(sheng)(sheng)化制(zhi)(zhi)(zhi)藥為(wei)(wei)主體(ti)的(de)(de)(de)(de)(de),集科研、生(sheng)(sheng)產(chan)(chan)(chan)、經營一體(ti)化的(de)(de)(de)(de)(de)重點(dian)(dian)高新(xin)技(ji)術企(qi)業。是山東(dong)定點(dian)(dian)的(de)(de)(de)(de)(de)國(guo)(guo)家血(xue)液(ye)制(zhi)(zhi)(zhi)品(pin)(pin)生(sheng)(sheng)產(chan)(chan)(chan)企(qi)業。公(gong)(gong)司(si)(si)總部設在山東(dong)泰(tai)安(an)(an)。在泰(tai)安(an)(an)建有(you)(you)一個(ge)血(xue)液(ye)制(zhi)(zhi)(zhi)品(pin)(pin)生(sheng)(sheng)產(chan)(chan)(chan)基地和(he)血(xue)液(ye)制(zhi)(zhi)(zhi)品(pin)(pin)研究中(zhong)(zhong)心。公(gong)(gong)司(si)(si)現有(you)(you)人血(xue)白(bai)(bai)蛋(dan)白(bai)(bai)、人免(mian)(mian)(mian)疫球(qiu)(qiu)蛋(dan)白(bai)(bai)、靜注人免(mian)(mian)(mian)疫球(qiu)(qiu)蛋(dan)白(bai)(bai)（pH4）、乙型肝炎人免(mian)(mian)(mian)疫球(qiu)(qiu)蛋(dan)白(bai)(bai)、狂犬病人免(mian)(mian)(mian)疫球(qiu)(qiu)蛋(dan)白(bai)(bai)、破傷風人免(mian)(mian)(mian)疫球(qiu)(qiu)蛋(dan)白(bai)(bai)、人凝血(xue)因子(zi)Ⅷ、人凝血(xue)酶原復合(he)物(wu)(wu)(wu)、人纖維蛋(dan)白(bai)(bai)原等9個(ge)品(pin)(pin)種，24個(ge)規格的(de)(de)(de)(de)(de)產(chan)(chan)(chan)品(pin)(pin)，產(chan)(chan)(chan)品(pin)(pin)批(pi)簽(qian)發合(he)格率100%，優質的(de)(de)(de)(de)(de)產(chan)(chan)(chan)品(pin)(pin)贏得了市場的(de)(de)(de)(de)(de)青睞(lai)。合(he)資(zi)(zi)以來，銷售收入年(nian)增長率超(chao)過50%。泰(tai)邦生(sheng)(sheng)物(wu)(wu)(wu)成立六年(nian)來,生(sheng)(sheng)產(chan)(chan)(chan)經營迅速擴(kuo)大(da),經濟(ji)取得長足發展。企(qi)業的(de)(de)(de)(de)(de)綜合(he)實力(li)從最初的(de)(de)(de)(de)(de)血(xue)液(ye)制(zhi)(zhi)(zhi)品(pin)(pin)行業第三梯(ti)隊(dui)上升為(wei)(wei)第一梯(ti)隊(dui)，產(chan)(chan)(chan)值利(li)潤等各項經濟(ji)指標統計的(de)(de)(de)(de)(de)綜合(he)實力(li)排名(ming),去年(nian)居全國(guo)(guo)血(xue)液(ye)制(zhi)(zhi)(zhi)品(pin)(pin)同行業位列前3位。目(mu)前，公(gong)(gong)司(si)(si)擁有(you)(you)一支國(guo)(guo)際(ji)化的(de)(de)(de)(de)(de)管理團隊(dui)，其中(zhong)(zhong)境外高管人士近半(ban)數，建立起了與國(guo)(guo)際(ji)化運作相適應的(de)(de)(de)(de)(de)管理隊(dui)伍。2009年(nian)12月(yue)公(gong)(gong)司(si)(si)控股股東(dong)—China Biologic Products, Inc.（中(zhong)(zhong)國(guo)(guo)生(sheng)(sheng)物(wu)(wu)(wu)制(zhi)(zhi)(zhi)品(pin)(pin)）于(yu)(yu)美國(guo)(guo)納斯達克成功(gong)上市（交(jiao)易代碼為(wei)(wei)NASDAQ:CBPO），為(wei)(wei)公(gong)(gong)司(si)(si)的(de)(de)(de)(de)(de)發展提供(gong)了強(qiang)大(da)的(de)(de)(de)(de)(de)資(zi)(zi)本支持， 2009年(nian)9月(yue)，中(zhong)(zhong)國(guo)(guo)生(sheng)(sheng)物(wu)(wu)(wu)制(zhi)(zhi)(zhi)品(pin)(pin)從12000多家候選上市公(gong)(gong)司(si)(si)中(zhong)(zhong)脫(tuo)穎而出，榮登《福布斯》公(gong)(gong)布2009亞(ya)洲200家中(zhong)(zhong)小企(qi)業榜單。